David Luyimbazi
- Co-authors
- Funda Meric‐BernstamArgun AkçakanatGopal K. SinghAna M. González-AnguloYuhuan ZhengDouglas J. GriderCurtis E. BowerFarrell Adkins
- Topics
- PI3K/AKT/mTOR signaling in cancer (7 papers)Cancer Treatment and Pharmacology (4 papers)Hepatocellular Carcinoma Treatment and Prognosis (3 papers)
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaCancer Research
- Partner nations
- United StatesHungaryTaiwan
In The Last Decade
David Luyimbazi
20 papers receiving 366 citations
Peers
Comparison fields: 5 of 66
- Molecular Biology 166
- Oncology 72
- Surgery 67
- Cancer Research 57
- Pulmonary and Respiratory Medicine 44
Countries citing papers authored by David Luyimbazi
This map shows the geographic impact of David Luyimbazi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Luyimbazi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Luyimbazi more than expected).
Fields of papers citing papers by David Luyimbazi
This network shows the impact of papers produced by David Luyimbazi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Luyimbazi. The network helps show where David Luyimbazi may publish in the future.
Co-authorship network of co-authors of David Luyimbazi
This figure shows the co-authorship network connecting the top 25 collaborators of David Luyimbazi. A scholar is included among the top collaborators of David Luyimbazi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Luyimbazi. David Luyimbazi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 9 | |
| 2 | 5 | |
| 3 | 11 | |
| 4 | 29 | |
| 5 | 2 | |
| 6 | 2 | |
| 7 | 15 | |
| 8 | 25 | |
| 9 | 46 | |
| 10 | 4 | |
| 11 | 11 | |
| 12 | 1 | |
| 13 | 3 | |
| 14 | 1 | |
| 15 | 5 | |
| 16 | 17 | |
| 17 | 60 | |
| 18 | 1 | |
| 19 | 80 | |
| 20 | 45 |
About David Luyimbazi
David Luyimbazi is a scholar working on Hepatology, Dermatology and Oncology, having authored 20 papers that have together received 372 indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (7 papers), Cancer Treatment and Pharmacology (4 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). The work is most often cited by research in Periodontics (23 citations), Biotechnology (33 citations) and Cancer Research (57 citations). David Luyimbazi has collaborated with scholars based in United States, Hungary and Taiwan. Frequent co-authors include Funda Meric‐Bernstam, Argun Akçakanat, Gopal K. Singh, Ana M. González-Angulo, Yuhuan Zheng, Douglas J. Grider, Curtis E. Bower, Farrell Adkins, Grace Spatafora and Michael Hudson. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.